你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
SFR3-DR5
SFR3-DR5
规格:
货期:
编号:TS210931
品牌:Testobio
产品名称: SFR3-DR5
商品货号: TS210931
Organism: Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Strain:

Strain:xa0 KGH (B cell); BALB/c (myeloma)

Applications:
Tested and found negative for ectromelia virus (mousepox).
Derivation:
Animals were immunized with purified DR antigen from obtained from the Swei human lymphoblastoid cell line.
Popliteal lymph node cells were fused with Sp2/0-Ag14 myeloma cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against HLA DR5
Cellular Products:
immunoglobulin; monoclonal antibody; against HLA DR5
Comments:
Animals were immunized with purified DR antigen from obtained from the Swei human lymphoblastoid cell line.
Popliteal lymph node cells were fused with Sp2/0-Ag14 myeloma cells.
Tested and found negative for ectromelia virus (mousepox).
Complete Growth Medium: The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing:
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Cryopreservation:
culture medium 95%; DMSO, 5%
Culture Conditions:
Temperature: 37.0°C
Isotype: IgG2b
Name of Depositor: SF Radka
Deposited As: rat (B cell); mouse (myeloma)
References:

Radka SF, et al. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity. J. Immunol. 130: 1863-1866, 1983. PubMed: 6187822

首页 > 产品中心 > 微生物培养 > 菌株 > null > SFR3-DR5

SFR3-DR5

  • 货号: TS210931
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: SFR3-DR5
商品货号: TS210931
Organism: Rattus norvegicus (B cell); Mus musculus (myeloma), rat (B cell); mouse (myeloma)
Cell Type: hybridoma: B lymphocyte
Product Format: frozen
Morphology: lymphoblast
Culture Properties: suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Strain:

Strain:xa0 KGH (B cell); BALB/c (myeloma)

Applications:
Tested and found negative for ectromelia virus (mousepox).
Derivation:
Animals were immunized with purified DR antigen from obtained from the Swei human lymphoblastoid cell line.
Popliteal lymph node cells were fused with Sp2/0-Ag14 myeloma cells.
Genes Expressed:
immunoglobulin; monoclonal antibody; against HLA DR5
Cellular Products:
immunoglobulin; monoclonal antibody; against HLA DR5
Comments:
Animals were immunized with purified DR antigen from obtained from the Swei human lymphoblastoid cell line.
Popliteal lymph node cells were fused with Sp2/0-Ag14 myeloma cells.
Tested and found negative for ectromelia virus (mousepox).
Complete Growth Medium: The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Subculturing:
Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
Cryopreservation:
culture medium 95%; DMSO, 5%
Culture Conditions:
Temperature: 37.0°C
Isotype: IgG2b
Name of Depositor: SF Radka
Deposited As: rat (B cell); mouse (myeloma)
References:

Radka SF, et al. SFR3-DR5, a monoclonal antibody with HLA-DR5 specificity. J. Immunol. 130: 1863-1866, 1983. PubMed: 6187822

合作单位: